Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Waheeda Sirah"'
Autor:
Anders G. Olsson, Fabian Chen, Christine McCrary Sisk, Waheeda Sirah, Darbie Maccubbin, Yale B. Mitchel, Harold E. Bays, Jennifer W. Anderson, Uma Kher
Publikováno v:
The American Journal of Cardiology. 110:817-822
Extended-release niacin (ERN) improves multiple lipid parameters but is underused owing to niacin-induced flushing (NIF). Laropiprant (LRPT) reduces NIF; however, its effects on chronic flushing (6 months) have not been studied. We examined whether a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10a674cd0221eb79ff78d7163537321c
https://doi.org/10.1016/j.amjcard.2012.05.009
https://doi.org/10.1016/j.amjcard.2012.05.009
Autor:
Debra Kush, Da Yi Hu, Christine McCrary Sisk, Waheeda Sirah, Hyo-Soo Kim, Ji Liu, John F. Paolini, Aditi Sapre, Darbie Maccubbin
Publikováno v:
Journal of Clinical Lipidology. 3:179-186
Niacin has proven lipid-modifying efficacy and cardiovascular benefit; however, it is underused because of skin flushing, a process mediated primarily by prostaglandin D(2) (PGD(2)). Laropiprant (LRPT), a PGD(2) receptor (DP1) antagonist that mitigat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f21e4e7eba9d5f23867e466b612fa6e
https://doi.org/10.1016/j.jacl.2009.04.048
https://doi.org/10.1016/j.jacl.2009.04.048
Autor:
Hyo-Soo Kim, Da-Yi Hu, Christine McCrary Sisk, Darbie Maccubbin, Waheeda Sirah, John F. Paolini, Erluo Chen, Debra Kush, Ping Ye
Publikováno v:
Cardiology. 114:192-198
Objective: Niacin is underutilized due to flushing, which occurs in over 90% of niacin-treated patients. Laropiprant (LRPT) reduces flushing associated with niacin. This study compared flushing with a combination tablet of extended-release (ER) niaci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6e622ff1e405b189490787107b880d4
https://doi.org/10.1159/000228585
https://doi.org/10.1159/000228585
Autor:
John F. Paolini, Abigaile Betteridge, Anders G. Olsson, Robert Reyes, A. Elis, C. McCrary Sisk, Qinfen Yu, Harold E. Bays, Waheeda Sirah, Olga M. Kuznetsova, Richard C. Pasternak, Darbie Maccubbin, V. Elinoff, Yale B. Mitchel
Publikováno v:
International Journal of Clinical Practice. 62:1959-1970
Summary Background: Improving lipids beyond low-density lipoprotein cholesterol (LDL-C) lowering with statin monotherapy may further reduce cardiovascular risk. Niacin has complementary lipid-modifying efficacy to statins and cardiovascular benefit,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b45ac1704417c2a1a82326009d07d8b
https://doi.org/10.1111/j.1742-1241.2008.01938.x
https://doi.org/10.1111/j.1742-1241.2008.01938.x
Autor:
Geraldine Macdonell, Dieter Lütjohann, Thomas Musliner, Waheeda Sirah, J. Lin, Amish P. Shah, Amy O. Johnson-Levonas, Aditi Sapre, K. von Bergmann
Publikováno v:
International Journal of Clinical Practice. 62:1499-1510
Summary Objective: To assess the long-term efficacy and safety profile of ezetimibe 10 mg/day in patients with homozygous sitosterolemia. Methods: This was an extension of a multi-centre, randomised, double-blind, placebo-controlled base study in whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84db3dadbb5e96230b74cc385886169f
https://doi.org/10.1111/j.1742-1241.2008.01841.x
https://doi.org/10.1111/j.1742-1241.2008.01841.x
Autor:
Gerald Salen, Waheeda Sirah, C. McCrary Sisk, K. von Bergmann, Thomas Musliner, Dieter Lütjohann, Aditi Sapre, D. Cselovszky
Publikováno v:
International Journal of Clinical Practice. 62:995-1000
Summary Objective: To assess the effect of ezetimibe (EZE) 40 mg/day on non-cholesterol sterol plasma concentrations in patients with homozygous sitosterolaemia (HoS). Methods: This was a multi-centre, randomised, double-blind, placebo-controlled par
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c24c6c2dfd9ad18f18cacd959bd4cbf
https://doi.org/10.1111/j.1742-1241.2008.01786.x
https://doi.org/10.1111/j.1742-1241.2008.01786.x
Autor:
Luzelena Caro, Cynthia Cuffie, Yale B. Mitchel, Dominic P. Behan, Richard L. Dunbar, Laurence B. Peterson, Jiajun Liu, John F. Paolini, Daniel T. Connolly, Steven L. Colletti, Tsuei-Ju Wu, Graeme Semple, P. Douglas Boatman, Josee Cote, Kenneth K. Wu, Waheeda Sirah, Jayne Chin, Samuel D. Wright, Andrew K.P. Taggart, John A. Wagner, Daniel J. Rader, Brett Lauring, James R. Tata, Kang Cheng, Andrew S. Plump, M. Gerard Waters, Lan Jin, Alexandra MacLean, Sauzanne Khalilieh, Adam B. Polis, Wen-Lin Luo, Eseng Lai, Xuan Liu
Publikováno v:
Science translational medicine. 4(148)
Nicotinic acid (niacin) induces beneficial changes in serum lipoproteins and has been associated with beneficial cardiovascular effects. Niacin reduces low-density lipoprotein, increases high-density lipoprotein, and decreases triglycerides. It is we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebf1aeccbf331668a9796c2e9933ab38
https://pubmed.ncbi.nlm.nih.gov/22914620
https://pubmed.ncbi.nlm.nih.gov/22914620
Autor:
Erluo Chen, Peder Blomqvist, Fabian Chen, Waheeda Sirah, Lizhen Yan, Michael H. Davidson, Christine McCrary Sisk, James M. McKenney, Darbie Maccubbin
Publikováno v:
International journal of cardiology. 167(1)
Extended-release niacin/laropiprant (ERN/LRPT) reduces flushing and preserves the lipid-modifying effects of ERN. This study compared the efficacy and safety of ERN/LRPT plus simvastatin (ERN/LRPT+SIMVA) with atorvastatin (ATORVA) in patients with mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83280196e94a9938a4dc6f4981ad34a4
https://pubmed.ncbi.nlm.nih.gov/22305632
https://pubmed.ncbi.nlm.nih.gov/22305632
Autor:
John K. Troxell, Claude Gagné, Pedro Mata, Waheeda Sirah, Luis Masana, Alan G. Meehan, Barry Gumbiner, Amy O. Johnson-Levonas, Meehyung Cho
Publikováno v:
Clinical therapeutics. 27(2)
Background: Ezetimibe (EZE) is a cholesterol-loweringdrug that inhibits absorption of dietary and biliary cholesterol across the intestinal wall without affecting absorption of bile acids, fatty acids, fat-soluble vitamins, or triglycerides. It has a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a6e0445666e53286977a6801359cf84
https://pubmed.ncbi.nlm.nih.gov/15811480
https://pubmed.ncbi.nlm.nih.gov/15811480
Autor:
Thomas Musliner, K. von Bergmann, Waheeda Sirah, D. Luetjohann, J. Lin, Amish P. Shah, Aditi Sapre, Amy O. Johnson-Levonas
Publikováno v:
Atherosclerosis Supplements. 9:189
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22d7b2591e67df00a8df89e0d6087fe5
https://doi.org/10.1016/s1567-5688(08)70759-1
https://doi.org/10.1016/s1567-5688(08)70759-1